Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
Abstract Background This study investigated patients' preference for allergy immunotherapy (AIT) administered as either sublingual immunotherapy‐tablets versus monthly or weekly subcutaneous immunotherapy (SCIT) from a Spanish patient perspective. Methods A discrete choice experiment (DCE) cons...
Main Authors: | Mette Bøgelund, Ana Rosado Ingelmo, Jose María Ausín Ruiz, Adolfo Galán Vivó, Henrik Brandi, Mikkel Hasse Pedersen, Anne Sofie Ledgaard Loftager, Mark Aagren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Clinical and Translational Allergy |
Subjects: | |
Online Access: | https://doi.org/10.1002/clt2.12118 |
Similar Items
-
Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy
by: Yingyang Xu, et al.
Published: (2022-01-01) -
Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer
by: Hao Yang, et al.
Published: (2023-03-01) -
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
by: Montserrat Alvaro‐Lozano, et al.
Published: (2022-01-01) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
by: Tankersley M, et al.
Published: (2021-11-01) -
Management of patients with seasonal allergic rhinitis: Diagnostic consideration of sensitization to non‐frequent pollen allergens
by: Conny Höflich, et al.
Published: (2021-10-01)